CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN, CHINA – China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of the… Read More

Operation HOPE Global Initiative Expands HOPE AI with Support from Martin Eichenfels and Annika Rosenberg

Germany, 23rd Jun 2026 – As artificial intelligence continues to move from research laboratories into everyday life, discussions surrounding digital literacy, technological awareness, and responsible AI adoption have become increasingly relevant across industries. From education and healthcare to finance and business operations, AI technologies are… Read More

GPAP Questions Pan Shiyi’s U.S. Legitimacy Network

Group says philanthropy, elite affiliations and iconic assets may help foreign billionaire families reshape public identity WASHINGTON, D.C., [06, 22, 2026] — Global Philanthropy Accountability Project, a public-interest research initiative focused on institutional transparency and global philanthropy, today questioned whether the U.S. public has enough… Read More